Companies/EU/COPN

COSMO N.V.

Ownership & governance

Executives 5Directors 7Avg age 57Avg tenure 7.9y
Giovanni di Napoli
Chief Executive Officer
Age 52Since 2024-05-23Profile →

Shareholders5

NameStakeShares
Mauro Ajani
35.04 %
6,147,252
Gerald Herz
7.995 %
1,402,631
dievini Hopp BioTech holding GmbH & Co. KG
3.797 %
666,062
COSMO N.V.
2.99 %
524,551
CA Indosuez Fund Solutions SA
0.2787 %
48,900

Catalog · 2026-07-09

Registry officers12

NameRoleSinceShares
Alessandro Della ChàChairman2024-05-23-
Davide MalavasiChief Tech/Sci/R&D Officer2011-08-31-
Giovanni di NapoliChief Executive Officer2024-05-23-
Luigi LongoChief Tech/Sci/R&D Officer2005-05-31-
Mauro AjaniChairman2013-12-31-
Paolo LanzarottiChief Tech/Sci/R&D Officer2008-12-31-
Svetlana SigalovaDirector of Finance/CFO2024-11-10-
Giovanni di NapoliDirector/Board Member2024-05-23-

Registry · as of 2026-07-09

Group companies

NameCategory
Granell Strategic Investment Fund Ltd.Investment Managers
Granell Strategic Investment Fund Ltd.Investment Managers
Cosmo Technologies Ltd.Pharmaceuticals: Major
Cosmo Technologies Ltd.Pharmaceuticals: Major
CASSIOPEA S.P.A.Pharmaceuticals: Major

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus none

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers